Vennlig påminnelse til alle som sender pakker
All informasjon om pakker som skal sendes
må sendes til ekspedisjon@biomed.uib.no.
Nytt fra Institutt for biomedisin
News from the Department of Biomedicine
Application Deadline: 18 September 2024
CAS har en avtale med UiB som sikrer at den/de som får tilbud fra oss, får fri med lønn for å lede gruppen sin på CAS. Men før man søker må man innhente støttebrev fra nærmeste leder. Dette garanterer at enheten har budsjettmessig dekning for perioden med forskningsfri dersom søknaden innvilges. En generell erfaring fra tidligere søknadsrunder er at ellers gode søknader ofte har falt gjennom fordi man ikke har tydeliggjort hva et opphold ved CAS vil bety for prosjektet og forskerkarrieren. For å rette på dette har vi nå fått en egen kontaktperson på UiB, Jutta Schloon (jutta.schloon@uib.no), som kan bistå søkerne med informasjon om prosessen.
For andre spørsmål se https://cas-nor.no/faq. Med vennlig hilsen, på vegne av styreleder Rolf K. Reed og direktør Camilla Serck-Hanssen,
Nyhetsbrev fra Institutt for Biomedisin
Bilder er enten fra UiB.no eller www.freepik.com
Publisert hver tredje uke
Ansvarlig redaktør: Frode Berven
Redaktør: Anne Mette Søviknes
Anette Siggervåg ble tilsatt 01.04.2024 i 4-årig stipendiatstilling hos Henriette Aksnes finansiert av Trond Mohn Stiftelse og UiB.
Bar3 18 april, kl 18.00
10.04.2024 – 09.00–11.00, BB-building, Room: 4C11F – Histologisal 3 on 4th floor
Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability.
Zhao F, Yao Z, Li Y, Zhao W, Sun Y, Yang X, Zhao Z, Huang B, Wang J, Li X, Chen A.Cancer Lett. 2024 Apr 4:216844. doi: 10.1016/j.canlet.2024.216844. Online ahead of print.PMID: 38582394
What makes mentors thrive? An exploratory study of their satisfaction in undergraduate medical education.
Skjevik EP, Schei E, Boudreau JD, Tjølsen A, Ringberg U, Fuks A, Kvernenes M, Ofstad EH.BMC Med Educ. 2024 Apr 4;24(1):372. doi: 10.1186/s12909-024-05344-y.PMID: 38575953 Free PMC article.
Generation of an enhancer-driven gene expression viral tool specific to dentate granule cell-types through direct hippocampal injection.
Potenza ML, Blankvoort S, Carvalho MM, Grimstvedt JS, Di Maria V, Moan K, Nair RR, Flatset MS, Zhang Q, Thomas LF, Pauzin FP, Da Silva Mazzarini Baldinotti R, Quattrocolo G, Bramham CR, Sætrom P, Witter MP, Kentros CG.Front Neurosci. 2024 Mar 14;18:1274174. doi: 10.3389/fnins.2024.1274174. eCollection 2024.PMID: 38550563 Free PMC article.
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
Lereim RR, Nytrova P, Guldbrandsen A, Havrdova EK, Myhr KM, Barsnes H, Berven FS. PLoS One. 2024 Mar 25;19(3):e0300914. doi: 10.1371/journal.pone.0300914. eCollection 2024.PMID: 38527011 Free PMC article.
Protein N-terminal acetylation is entering the degradation end game.
Arnesen T, Kjosås I, McTiernan N. Nat Rev Mol Cell Biol. 2024 Mar 22. doi: 10.1038/s41580-024-00723-1. Online ahead of print.PMID: 38519774 No abstract available.
Blind deconvolution decreases requirements on temporal resolution of DCE-MRI: Application to 2nd generation pharmacokinetic modeling.
Kratochvíla J, Jiřík R, Bartoš M, Standara M, Starčuk Z Jr, Taxt T. Magn Reson Imaging. 2024 Jun;109:238-248. doi: 10.1016/j.mri.2024.03.019. Epub 2024 Mar 19.PMID: 38508292
Local patterns of genetic sharing challenge the boundaries between neuropsychiatric and insulin resistance-related conditions.
Fanelli G, Franke B, Fabbri C, Werme J, Erdogan I, De Witte W, Poelmans G, Ruisch IH, Reus LM, van Gils V, Jansen WJ, Vos SJB, Alam KA, Martinez A, Haavik J, Wimberley T, Dalsgaard S, Fóthi Á, Barta C, Fernandez-Aranda F, Jimenez-Murcia S, Berkel S, Matura S, Salas-Salvadó J, Arenella M, Serretti A, Mota NR, Bralten J. medRxiv [Preprint]. 2024 Mar 8:2024.03.07.24303921. doi: 10.1101/2024.03.07.24303921.PMID: 38496672 Free PMC article. Preprint.
Genome-wide association study identifies new loci associated with OCD.
Strom NI, Halvorsen MW, Tian C, Rück C, Kvale G, Hansen B, Bybjerg-Grauholm J, Grove J, Boberg J, Nissen JB, Damm Als T, Werge T, de Schipper E, Fundin B, Hultman C, Höffler KD, Pedersen N, Sandin S, Bulik C, Landén M, Karlsson E, Hagen K, Lindblad-Toh K; Nordic OCD and Related Disorders Consortium (NORDiC); 23andMe Research Team; PGC TS/OCD working group; Hougaard DM, Meier SM, Hellard SL, Mors O, Børglum AD, Haavik J, Hinds DA, Mataix-Cols D, Crowley JJ, Mattheisen M.medRxiv [Preprint]. 2024 Mar 8:2024.03.06.24303776. doi: 10.1101/2024.03.06.24303776.PMID: 38496634 Free PMC article. Preprint.
TBD
Thursday, April 25, 14:30
March 21, CCBIO seminar, Mika Kontro, Helsinki University Hospital Comprehensive Cancer Center, Finland
April 11, BBB seminar, Helge Wiig, Department of Biomedicine, University of Bergen
April 25, CCBIO seminar, TBD
May 23, BBB seminar, Karin Dedek, University of Oldenburg, Germany
May 30, CCBIO seminar, Antonio Curti, University of Bologna, Italy
June 6, BBB seminar, Ylva Hellsten, University of Copenhagen, Denmark
June 20, CCBIO seminar, TBD
2nd Research Day at the Faculty of Medicine | Faculty of Medicine | UiB
18 June, EITRI
Norsk: Kommende arrangement for Forsknings- og innovasjonsavdelingen | Universitetet i Bergen (uib.no)
English: Upcoming events for Division of Research and Innovation | University of Bergen (uib.no)
Norsk: Kommende arrangement for Universitetsbiblioteket | Universitetet i Bergen (uib.no)
English: Upcoming events for University of Bergen Library | University of Bergen (uib.no)
Norsk: Digital forståelse, kunnskap og kompetanse | Universitetet i Bergen (uib.no)
English: Digital understanding, knowledge and competence | University of Bergen (uib.no)
Sjå opptak av søker webinar (forskningsradet.no)
Arrangementer – Alrek (alrekhelseklynge.no)
Norsk: Nyheter og pressemeldinger (forskningsradet.no)
English: News (forskningsradet.no)
Stipendiatstillingene:
Stipendiat (12 stillingar) ved Det medisinske fakultet (259971) | Universitetet i Bergen (jobbnorge.no)
Postdoktorstillingene:
Postdoktor (2 stillingar) ved Det medisinske fakultet (259962) | Universitetet i Bergen (jobbnorge.no)
Søknadsfristen er 15. april 2024.
Newsletter: Newsletter – March 2024.pdf (uib.no)
Events: Upcoming events for International Centre | University of Bergen (uib.no)
Upcoming events for UiB Ferd Career Center for Early Stage Researchers | University of Bergen
Newsletter: April 2024 (cloud.microsoft)
COURSES | nordoc (nordochealth.net)
SERVICES – Elixir Norway
For any inquiries, the ELIXIR Norway Helpdesk can be reached through: support@elixir.no
Les strategien her: En strategi for fremtidens utfordringer (forskningsradet.no)
Nyhetsbrev fra Institutt for Biomedisin
Bilder er enten fra UiB.no eller www.freepik.com
Publisert hver tredje uke
Ansvarlig redaktør: Frode Berven
Redaktør: Anne Mette Søviknes
Dear colleagues,
Spring is upon us, a period that symbolizes a time of growth and hope. Our potential and hope for growth in research lies in leveraging our opportunities for external funding. Much like the natural world awakening around us this time of year, we must be awake and ready for the relevant calls ahead of us!
The Norwegian Cancer Society open call is coming up now, with deadline 28 May 2024. The call is not published yet but will be soon. We have had a steep decline in terms of the number of submitted applications from IBM the last years. So, I encourage everybody that is eligible and working with cancer research relevant to this call to apply this year.
The Research Council has announced that the call for Centre for Excellence Scheme (SFF-VI) will be published in spring 2025. It will be a two-step application process. The first application deadline is at the end of 2025, while the deadline for Phase II applications is planned for autumn 2026. The awards are scheduled to be made at the end of 2027. The Research Council will hold an open information meeting about the call during spring 2024, and there are also plans for applicant webinars once the call has been published. The faculty has developed a form where researchers are asked to describe the theme of the initiative and which partners might be considered to join the center. You will find the form at this link.
The internal deadline for submitting initiatives to the faculty through this link is set for May 15, 2024. The University of Bergen will allocate earmarked incentive funds, which will be distributed in two rounds, the first round being in the spring of 2024. SFF is a great opportunity for long term funding, either as coordinator or as participant. The competition will of course be tough, so I encourage you to actively seek partners for this call already now to be in a good position when the call is out.
Please visit this website regularly to obtain updated information about external research funding calls: Application Support for External Funding | Faculty of Medicine | UiB
The Faculty Day 2024 will be held on Wednesday, April 17th at 9 am in the auditorium of Armauer Hansen’s building – please reserve the time.
Nettside med informasjon og søknadsskjema for forskningstermin ved MED: https://www.uib.no/med/111864/forskningstermin.
Frist for å sende søknad til instituttet på e-post til adm.biomedisin@uib.no er 1. april.
Merk at du selv må finne erstatter til eventuelle undervisningsforpliktelser du måtte ha i den perioden som du søker forskningstermin for.
Dersom du ikke finner erstatter, kan instituttledelsen bistå med å finne det. Dette bør i alle fall være på plass før søknadsfristen og det må skrives inn i søknadsskjemaet hvem som skal dekke opp for deg mens du er ute i forskningstermin.
Søknadsfrist 1. april 2024
Vi har mindre post ved instituttet og derfor samler vi oss nå til å bare ha posthyller til 6 etasje
We have less mail at the institute and therefore we are now concentrating on only having mail shelves for the 6th floor
Biallelic NAA60 variants with impaired n-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications.
Chelban V, Aksnes H, Maroofian R, LaMonica LC, Seabra L, Siggervåg A, Devic P, Shamseldin HE, Vandrovcova J, Murphy D, Richard AC, Quenez O, Bonnevalle A, Zanetti MN, Kaiyrzhanov R, Salpietro V, Efthymiou S, Schottlaender LV, Morsy H, Scardamaglia A, Tariq A, Pagnamenta AT, Pennavaria A, Krogstad LS, Bekkelund ÅK, Caiella A, Glomnes N, Brønstad KM, Tury S, Moreno De Luca A, Boland-Auge A, Olaso R, Deleuze JF, Anheim M, Cretin B, Vona B, Alajlan F, Abdulwahab F, Battini JL, İpek R, Bauer P, Zifarelli G, Gungor S, Kurul SH, Lochmuller H, Da’as SI, Fakhro KA, Gómez-Pascual A, Botía JA, Wood NW, Horvath R, Ernst AM, Rothman JE, McEntagart M, Crow YJ, Alkuraya FS, Nicolas G; SYNaPS Study Group; Arnesen T, Houlden H.
Nat Commun. 2024 Mar 13;15(1):2269. doi: 10.1038/s41467-024-46354-0.PMID: 38480682 Free PMC article.
Hallmark Molecular and Pathological Features of POLG Disease are Recapitulated in Cerebral Organoids.
Chen A, Yangzom T, Hong Y, Lundberg BC, Sullivan GJ, Tzoulis C, Bindoff LA, Liang KX.
Adv Sci (Weinh). 2024 Mar 6:e2307136. doi: 10.1002/advs.202307136. Online ahead of print.PMID: 38445970
Inflammation, the kynurenines, and mucosal injury during human experimental enterotoxigenic Escherichia coli infection.
Rim S, Vedøy OB, Brønstad I, McCann A, Meyer K, Steinsland H, Hanevik K.
Med Microbiol Immunol. 2024 Mar 2;213(1):2. doi: 10.1007/s00430-024-00786-z.PMID: 38430452 Free PMC article.
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku’ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ; MISEV Consortium; Théry C, Witwer KW.
Participan from MISEV Consortium –Taral R Lunavat
J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404.PMID: 38326288 Free PMC article.
Thursday, March 21, 14:30
BBB Seminar
March 21, CCBIO seminar, Mika Kontro, Helsinki University Hospital Comprehensive Cancer Center, Finland
April 11, BBB seminar, Helge Wiig, Department of Biomedicine, University of Bergen
April 25, CCBIO seminar, TBD
May 23, BBB seminar, Karin Dedek, University of Oldenburg, Germany
May 30, CCBIO seminar, Antonio Curti, University of Bologna, Italy
June 6, BBB seminar, Ylva Hellsten, University of Copenhagen, Denmark
June 20, CCBIO seminar, TBD
Norsk: Kommende arrangement for Forsknings- og innovasjonsavdelingen | Universitetet i Bergen (uib.no)
English: Upcoming events for Division of Research and Innovation | University of Bergen (uib.no)
Norsk: Kommende arrangement for Universitetsbiblioteket | Universitetet i Bergen (uib.no)
English: Upcoming events for University of Bergen Library | University of Bergen (uib.no)
Norsk: Digital forståelse, kunnskap og kompetanse | Universitetet i Bergen (uib.no)
English: Digital understanding, knowledge and competence | University of Bergen (uib.no)
Sjå opptak av søker webinar (forskningsradet.no)
Arrangementer – Alrek (alrekhelseklynge.no)
Norsk: Nyheter og pressemeldinger (forskningsradet.no)
English: News (forskningsradet.no)
The Faculty of Medicine is awarding up to four stipends of max. 50.000 NOK for students with internship in a company summer of 2024.The scholarship is linked to an internship in a company of a minimum of six weeks (full-time) in the summer months. The student must contribute to the company’s value creation, and gain insight into product development and processes related to marketing/sales.
Sommerstipend innovasjon | Det medisinske fakultet | UiB
Application deadline 3. April
Newsletter: Newsletter – February 2024.pdf (uib.no)
Upcoming events for UiB Ferd Career Center for Early Stage Researchers | University of Bergen
Newsletter: April 2024 (cloud.microsoft)
COURSES | nordoc (nordochealth.net)
SERVICES – Elixir Norway
For any inquiries, the ELIXIR Norway Helpdesk can be reached through: support@elixir.no
Nyhetsbrev fra Institutt for Biomedisin
Bilder er enten fra UiB.no eller www.freepik.com
Publisert hver tredje uke
Ansvarlig redaktør: Frode Berven
Redaktør: Anne Mette Søviknes
Dear all;
It has been hectic activity in our building the last days, relocating people in the different floors of the department. The administrative staff has moved from 6th floor to 7th floor, while scientific staff has been relocated according to which research unit they are belonging to. The process of moving permanent staff is now finished, while a few of the temporarily employed people (PhDs, post docs, others) still will be relocated. It must be said that the whole process has been as smooth as one can expect, and people have been showing a very positive attitude towards the whole process.
Further, I would like to highlight two ongoing projects in the INTPART programme, funded by NRC and coordinated by Scientific staff at IBM. INTPART was initiated with the aim to enhance collaboration between higher education institutions in Norway and their counterparts abroad, particularly focusing on countries of strategic importance.
The INTPART project «Partnership on Central Nervous System Malignancies» (Rolf Bjerkvig-coordinator) has participants from UiB, Shandong University (Jinan, China), Wuhan National Laboratory (China), and MD Anderson Cancer Center (Houston, TX). The overall objective is to develop outstanding research and education in Norway and abroad on malignant brain tumors. We have organized courses in tumor biology and imaging and performed staff and student exchanges between China and Norway. A 3-day final conference has just been arranged at Solstrand Fjordhotell with approximately 40 participants, focusing on courses in neuropathology, drug design, and scientific project achievements. The project finishes end of February 2024.
The INTPART project “VitaCross” (a training platform in systems medicine) has participants from UiB (Mathias Ziegler-coordinator), UiT, the University of South Alabama (Mitchell Cancer Center) and the University of Groningen (Medical Center). VitaCross organizes joint courses in systems biology, medicinal chemistry, cancer biology, computational modeling and other technologies. Two courses take place each year, as well as joint workshops and staff exchanges. Currently, we conduct a 2-week course in Bergen (at Eitri) on metabolic pathway analyses jointly with the Norwegian Research School on Bioinformatics, Biostatistics and Systems Biology (NORBIS). This project ends March 2026.
During the HMS Day at the Medical Faculty on Feb 21th, the “Work Environment Award” (Arbeidsmiljøprisen) for 2023 was awarded to Fellesavdelingen at IBM, for their outstanding efforts during the implementation of the OSKE exam. Congratulations! For more information, see https://www.uib.no/med/168779/teknisk-fellesavdeling-ved-ibm-ble-hedret-med-arbeidsmiljøpris.
Finally, this week is winter holiday, and I hope that all of you will have a nice week, whether you take a few days off, or you will be at work.
Best regards
Frits
Teknisk fellesavdeling ved IBM kunne glede seg over en fin pengepremie som vinnere av årets arbeidsmiljøpris. Pengene skal gå til HMS-tiltak ved enheten. Foto/ill.: Paul André Sommerfeldt
Nettside med informasjon og søknadsskjema for forskningstermin ved MED: https://www.uib.no/med/111864/forskningstermin.
Frist for å sende søknad til instituttet på e-post til adm.biomedisin@uib.no er 1. april.
Merk at du selv må finne erstatter til eventuelle undervisningsforpliktelser du måtte ha i den perioden som du søker forskningstermin for.
Dersom du ikke finner erstatter, kan instituttledelsen bistå med å finne det. Dette bør i alle fall være på plass før søknadsfristen og det må skrives inn i søknadsskjemaet hvem som skal dekke opp for deg mens du er ute i forskningstermin.
Newsletter: Newsletter – February 2024.pdf (uib.no)
Kommende arrangement for HMS-portalen | Universitetet i Bergen (uib.no)
Take the chance to get to know your fellow students while at the same time practicing your spoken Norwegian!
The language café will be open to ALL UiB students every Tuesday at 16-18.
Babelstuen, Universitetsbiblioteket Humaniora, Haakon Sheteligs plass
Compositional plaque progression in women and men with non-obstructive coronary artery disease.
Hondros CAB, Khan I, Solvik M, Hanseth S, Pedersen EKR, Hovland S, Larsen TH, Lønnebakken MT. Int J Cardiol Heart Vasc. 2024 Feb 7;51:101352. doi: 10.1016/j.ijcha.2024.101352. eCollection 2024 Apr.PMID: 38356931 Free PMC article.
Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.
Ji J, Ding K, Cheng B, Zhang X, Luo T, Huang B, Yu H, Chen Y, Xu X, Lin H, Zhou J, Wang T, Jin M, Liu A, Yan D, Liu F, Wang C, Chen J, Yan F, Wang L, Zhang J, Yan S, Wang J, Li X, Chen G. Adv Sci (Weinh). 2024 Feb 11:e2304609. doi: 10.1002/advs.202304609. Online ahead of print.PMID: 38342629
Structural basis for excitatory neuropeptide signaling.
Kalienkova V, Dandamudi M, Paulino C, Lynagh T. Nat Struct Mol Biol. 2024 Feb 9. doi: 10.1038/s41594-023-01198-y. Online ahead of print.PMID: 38337033
HTRA1 promotes EMT through the HDAC6/Ac-α-tubulin pathway in human GBM cells.
Zhao W, Wu Y, Wang S, Zhao F, Liu W, Xue Z, Zhang L, Wang J, Han M, Li X, Huang B. CNS Neurosci Ther. 2024 Feb;30(2):e14605. doi: 10.1111/cns.14605.PMID: 38334007 Free PMC article.
Overlay databank unlocks data-driven analyses of biomolecules for all.
Kiirikki AM, Antila HS, Bort LS, Buslaev P, Favela-Rosales F, Ferreira TM, Fuchs PFJ, Garcia-Fandino R, Gushchin I, Kav B, Kučerka N, Kula P, Kurki M, Kuzmin A, Lalitha A, Lolicato F, Madsen JJ, Miettinen MS, Mingham C, Monticelli L, Nencini R, Nesterenko AM, Piggot TJ, Piñeiro Á, Reuter N, Samantray S, Suárez-Lestón F, Talandashti R, Ollila OHS. Nat Commun. 2024 Feb 7;15(1):1136. doi: 10.1038/s41467-024-45189-z.PMID: 38326316 Free PMC article.